Evidence map›Paper›PMID 30140877›Full record

Observational studyJAMA2018

Association of Cardiovascular Risk Factors With MRI Indices of Cerebrovascular Structure and Function and White Matter Hyperintensities in Young Adults.

Wilby Williamson, Adam J Lewandowski, Nils D Forkert, Ludovica Griffanti, Thomas W Okell, Jill Betts, Henry Boardman, Timo Siepmann, David McKean, Odaro Huckstep and 10 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in JAMA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 3 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 3 syntheses or guidelines pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Polypills in the Management of Cardiovascular Risk-A Perspective.Journal of clinical medicine · 2024 · on this map
    Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 3 countries.

Wilby WilliamsonOxford Cardiovascular Clinical Research Facility, University of Oxford, Oxford, United Kingdom.
Adam J LewandowskiOxford Cardiovascular Clinical Research Facility, University of Oxford, Oxford, United Kingdom.
Nils D ForkertDepartment of Radiology and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Ludovica GriffantiWellcome Centre for Integrative Neuroimaging, FMRIB Division, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Thomas W OkellWellcome Centre for Integrative Neuroimaging, FMRIB Division, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Jill BettsOxford Cardiovascular Clinical Research Facility, University of Oxford, Oxford, United Kingdom.
Henry BoardmanOxford Cardiovascular Clinical Research Facility, University of Oxford, Oxford, United Kingdom.
Timo SiepmannDepartment of Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
David McKeanDepartment of Radiology, Stoke Mandeville Hospital, Buckinghamshire NHS Trust, Buckinghamshire, England, United Kingdom.
Odaro HuckstepOxford Cardiovascular Clinical Research Facility, University of Oxford, Oxford, United Kingdom.
Jane M FrancisOxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Stefan NeubauerOxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Renzo PhellanDepartment of Radiology and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Mark JenkinsonWellcome Centre for Integrative Neuroimaging, FMRIB Division, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Aiden DohertyNuffield Department of Population Health, BHF Centre of Research Excellence and Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom.
Helen DawesFaculty of Health and Life Sciences, Oxford Brookes University, Oxford, Oxford, United Kingdom.
Eleni FrangouCentre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
Christina MalamateniouSchool of Biomedical Engineering and Imaging Sciences, King's College London, United Kingdom.
Charlie FosterSchool of Policy Studies, University of Bristol, Bristol, United Kingdom.
Paul LeesonOxford Cardiovascular Clinical Research Facility, University of Oxford, Oxford, United Kingdom.
University of Oxford · GBJohn Radcliffe Hospital · GBUniversity of Calgary · CABuckinghamshire Healthcare NHS Trust · GBKing's College London · GBNuffield Orthopaedic Centre · GBOxford Brookes University · GBUniversity Hospital Carl Gustav Carus · DEUniversity of Bristol · GB

Funding

British Heart Foundation FS/18/3/33292British Heart Foundation PG/17/13/32860Wellcome Trust
6 · The paper itself

Abstract

Importance: Risk of stroke and brain atrophy in later life relate to levels of cardiovascular risk in early adulthood. However, it is unknown whether cerebrovascular changes are present in young adults. Objective: To examine relationships between modifiable cardiovascular risk factors and cerebrovascular structure, function, and white matter integrity in young adults. Design, Setting, and Participants: A cross-sectional observational study of 125 young adults (aged 18-40 years) without clinical evidence of cerebrovascular disease. Data collection was completed between August 2014 and May 2016 at the University of Oxford, United Kingdom. Final data collection was completed on May 31, 2016. Exposures: The number of modifiable cardiovascular risk factors at recommended levels, based on the following criteria: body mass index (BMI) <25; highest tertile of cardiovascular fitness and/or physical activity; alcohol consumption <8 drinks/week; nonsmoker for >6 months; blood pressure on awake ambulatory monitoring <130/80 mm Hg; a nonhypertensive diastolic response to exercise (peak diastolic blood pressure <90 mm Hg); total cholesterol <200 mg/dL; and fasting glucose <100mg/dL. Each risk factor at the recommended level was assigned a value of 1, and participants were categorized from 0-8, according to the number of risk factors at recommended levels, with higher numbers indicating healthier risk categories. Main Outcomes and Measures: Cerebral vessel density, caliber and tortuosity, brain white matter hyperintensity lesion count. In a subgroup (n = 52), brain blood arrival time and cerebral blood flow assessed by brain magnetic resonance imaging (MRI). Results: A total of 125 participants, mean (SD) age 25 (5) years, 49% women, with a mean (SD) score of 6.0 (1.4) modifiable cardiovascular risk factors at recommended levels, completed the cardiovascular risk assessment and brain MRI protocol. Cardiovascular risk factors were correlated with cerebrovascular morphology and white matter hyperintensity count in multivariable models. For each additional modifiable risk factor categorized as healthy, vessel density was greater by 0.3 vessels/cm3 (95% CI, 0.1-0.5; P = .003), vessel caliber was greater by 8 μm (95% CI, 3-13; P = .01), and white matter hyperintensity lesions were fewer by 1.6 lesions (95% CI, -3.0 to -0.5; P = .006). Among the 52 participants with available data, cerebral blood flow varied with vessel density and was 2.5 mL/100 g/min higher for each healthier category of a modifiable risk factor (95% CI, 0.16-4.89; P = .03). Conclusions and Relevance: In this preliminary study involving young adults without clinical evidence of cerebrovascular disease, a greater number of modifiable cardiovascular risk factors at recommended levels was associated with higher cerebral vessel density and caliber, higher cerebral blood flow, and fewer white matter hyperintensities. Further research is needed to verify these findings and determine their clinical importance.

Indexed as

Cerebrovascular CirculationMagnetic Resonance ImagingAdultBiomarkersBlood VesselsBody Mass IndexBrainCardiovascular DiseasesCholesterolCross-Sectional StudiesFemaleHumansMalePhysical FitnessRisk FactorsWhite MatterBiomarkersCholesterol

Identifiers

PMID30140877
PMCPMC6142949
OpenAlexW2818723673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.